PureHealth Holding PJSC (ADX: PUREHEALTH), the Middle East’s largest healthcare group, has announced robust financial results for the first half of 2025, reporting AED 13.6 billion in revenue—up 9% year-on-year—and a net profit of AED 1.03 billion, marking a 2% increase from the same period last year. EBITDA rose 8% to AED 2.3 billion.

The Group attributed this performance to broad-based growth across its two core verticals—Care (hospitals, procurement, diagnostics, and technology) and Cover (insurance). PureHealth’s streamlined operating model is designed to integrate healthcare delivery with insurance services, enhancing efficiency and transparency while offering investors clearer visibility into performance.

Key Financial Highlights (H1 2025):

• Care vertical contributed AED 9.8 billion (72% of total revenue), driven by higher patient volumes in the UAE and UK, alongside strong diagnostics and technology growth.
• Cover vertical revenue rose 14% to AED 3.8 billion, supported by an 8% increase in Gross Written Premiums (GWP) to AED 4.9 billion and a 6% rise in memberships.
• Net Debt to EBITDA ratio improved to 1.4x, with AED 1.85 billion in bank debt repaid ahead of 2027 maturity. The Group currently carries no bank debt.

Operational and Strategic Developments:

• Acquisition of Hellenic Healthcare Group (HHG), the largest private provider in Greece and Cyprus (pending regulatory approval).
• Circle Health Group expanded its UK footprint with the acquisition of Fairfield Independent Hospital in Merseyside.
• Daman entered the Property & Casualty segment, evolving into a multi-line insurer.
• SEHA’s SKMC partnered with Cincinnati Children’s Hospital to strengthen paediatric care in Abu Dhabi.
• Rafed appointed as exclusive distributor for Abu Dhabi’s Unified Purchasing Programme.
• PureLab testing volumes rose 19% to 16.9 million tests, while PureCS Technology Services revenue surged 170% to AED 367 million.

Chairman H.E. Kamal Al Maazmi emphasized PureHealth’s role in “building a global, future-ready healthcare ecosystem that is both technologically advanced and deeply human.” CEO Shaista Asif highlighted the Group’s focus on “synergies, AI-powered solutions, and international expansion to deliver better health outcomes.”

Outlook
Looking ahead, PureHealth plans to deepen investments in high-margin medical specialties, expand clinical centres of excellence, and accelerate digital health and AI integration. Its balanced strategy combines global M&A with organic growth, reinforcing its ambition to reshape healthcare delivery at scale.